At a glance
- Originator Yamanouchi
- Class Antineoplastics
- Mechanism of Action Steroid 17-alpha-hydroxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Prostate cancer
Most Recent Events
- 26 Jun 2001 No-Development-Reported for Prostate cancer in Japan (Unknown route)
- 13 Jan 1998 Preclinical development for Prostate cancer in Japan (Unknown route)